Two automated counters, the HI (Technicon) and the H6000 (Technicon), which count 10 000 cells per sample, were compared and used to examine the clinical relevance of the additional haematological information now provided to the rheumatologist in three groups of patients-38 with rheumatoid arthritis (RA), 41 with ankylosing spondylitis (AS), and 35 with systemic lupus erythematosus (SLE).
expected, both machines identified pancytopenia among the group with SLE, while low haemoglobin and high platelet count were found particularly among patients with RA and AS respectively. Additional information available from these counters showed marked variability in red cell size in SLE, and also of haemoglobin content, which is only measured on the newer HI machine. Flags for microcythaemia, anisochromasia, and white cell noise (usually due to nucleated red cells) were all more common in SLE. Interpretation of results was complicated by the inevitable difference in age and sex distribution among the disease groups, and identification of active disease was also limited by the effect of drugs.
In conclusion, the increasingly widespread use of automated counters as part of the routine haematological service may provide the rheumatologist with useful information, but, as always, care should be taken in the interpretation of indices in patients receiving non-steroidal or second line agents, and also in extrapolating results from one machine to another when they are updated or when patients are monitored at more than one centre.
Rheumatic diseases are accompanied by a variety of haematological abnormalities. For example, patients with rheumatoid arthritis (RA) may show hypochromic anaemial and thrombocytosis,2 especially in active disease; whereas patients with systemic lupus erythematosus (SLE) have been reported to show lymphopenia,3 basophilopenia,4 and neutrophil left shift. 5 Automated machines which count 10 000 cells per sample (compared with the 100 cells counted by traditional manual methods) have become a powerfil tool for assessing abnormalities among the cell populations in peripheral blood. Previous studies have used these techniques to document abnormalities in haematological indices associated with RA (as compared with a disease control group of patients with ankylosing spondylitis (AS))6 and with SLE. 7 As technology advances, however, newer machines have replaced the Hemalog D (Technicon) counter used in these studies, and these second generation machines perform to different specifications. Moreover, they are no longer just a research tool but are now standard equipment in most major haematology laboratories. A reappraisal of the haematological indices of rheumatic disease, as assessed by current automated counters, is warranted.
In this study two automated counters, the H6000 (Technicon) and HI (Technicon), were compared. A wide range of haematological indices were assessed in three groups of patients with rheumatic diseases-38 with RA, 41 with AS, and 35 with SLE-to establish whether these technical advances give consistent results, contribute to distinguishing the diseases, and whether they are affected by the level of disease activity and concomitant drug treatment.
Patients and methods

PATIENTS
Patients attending clinics in the Bloomsbury rheumatology unit during a six week study period were selected if (a) they were aged between 18 and 75, (b) they fulfilled the diagnostic criteria for one of the disease categories, and (c) venesection was carried out before 1400 hours, to allow the sample to be processed the same day. Each There are, however, certain methodological differences between the two instruments. On the H6000 basophils are specifically stained with alcian blue and counted in a separate channel, whereas on the HI machine sodium dodecyl sulphate is used to strip the cytoplasm from all cells, except basophils, which are then counted on the basis of size. Reactive lymphocytes and primitive cells negative for peroxidase are detected in both instruments as 'large unstained cells' on the peroxidase channel. In addition, the HI detects these on the basophil channel, rthrtis. and generates a 'blast' flag. The H6000 has automatically adjusting thresholds for the neutrophil population, but the HI has additional mobile thresholds for counting the other cell populations.
For the red cell population the mean cell volume on the H6000 is measured by summation of pulse heights, but on the HI a technique of computer generated 'red cell mapping' using laser light scatter from sphered red cells is used. The HI has the ability to generate graphical representations of red cell size distribution and haemoglobin content, and also measures variation in the haemoglobin content of red blood cells (haemoglobin distribution width). Finally, the HI is also physically smaller than the H6000 and does not require a supply of deionised water or a waste pipe attachment.
CALIBRATION OF COUNTERS
Both instruments were calibrated using fresh EDTA blood samples against the Coulter S-Plus IV counter, which used 4C Plus as the primary calibrant. This method of secondary calibration was used to ensure consistency of results from all instruments within the laboratory. As expected, increasing disease activity in patients with AS was associated with a fall in haemoglobin (p<002) and a rise in platelets (p<0 03) and, in particular, the percentage of platelets in whole blood (p<0003), but this association was not significant in RA. Active SLE, however, was associated with lower basophil counts than inactive SLE (p<0 03) on the H6000 machine, but not on the HI.
One of the problems in assessing the effect of treatment and disease activity in blood indices is that they may influence each other. For instance, it may only be the patients with more active disease who are taking non-steroidal antiinflammatory drugs (NSAIDs) or immunosuppressive drugs, but on the other hand, patients receiving such drug treatment may have their disease well controlled and display few signs of activity when studied. The following results are reported with these reservations in mind.
Twenty three of 41 (56%) patients with AS and 26 of 38 (68%) patients with RA were receiving NSAIDs. In RA, haemoglobin and packed cell volume were estimated by both machines to be significantly lower in those receiving NSAIDs (Mann-Whitney, p<002). Likewise, platelets and the percentage of platelets in whole blood were higher in patients with AS receiving NSAIDs on the HI (p<002), but not the H6000 machine. Only five of the patients with SLE were receiving NSAIDs, so no significant differences were found in this group.
Similarly, none of the patients with AS were receiving steroids or immunosuppressive drug treatment. Twenty one of 35 (60%) patients with SLE and 9/38 (24%) of those with RA were receiving steroids or immunosuppressive drugs (azathioprine or cyclophosphamide), or both. In patients with SLE steroid or immunosuppressive drug treatment, or both, was associated with higher red cell size distribution width and haemoglobin distribution width, and with eosinopenia and lymphopenia on the HI (p<002), and with basopenia and erythropenia on the H6000 (p<0 04). In patients with RA such treatment was associated with neutrophilia and lymphopenia, and higher haemoglobin distribution width, according to the HI (p<0.02).
Discussion
Since automated counters have become generally available much additional information and more variables are added to the conventional blood count. The purpose of this study was to assess whether this additional data is of clinical relevance to the rheumatologist in a study of three common rheumatic diseases. It is important to recognise, however, that this is a continuing process. Newer instruments are constantly coming into use. It is therefore pertinent to ask whether these different machines provide consistent information in their interpretation of the same peripheral blood sample. This study has focused on two counters in recent use, the HI (Technicon) and the H6000 (Technicon), but even in the time taken to prepare this paper the latter has already been superseded.
Certain important differences between the HI and the H6000 machines have been highlighted. These in turn reflect differences in design and in the techniques which the two instruments use to measure a given population of cells, as described in the 'Methods' section. Earlier reports, using manual counts, suggested that basopenia is associated with active disease in SLE.'3 This finding was not confirmed in the earlier study which used the Hemalog D,7 but our study reaffirms the association, at least on the H6000. The instruments may therefore be identifying different populations of cells, depending on their different clinical characteristics.
Particularly surprising was the marked discrepancy between mean platelet volume estimations on the two machines, which were consistently higher on the HI machine, often by as much as 300/o. Although it should be noted that the mean platelet volume is one of the most labile of the blood count indices, this difference may be artefactual. The mean platelet volume is to some extent time dependent, as platelets tend to shrink after venepuncture. Although every effort was made to process the samples simultaneously (and certainly on the same day), the H6000 was sited in another hospital, and the time which elapsed during transportation might therefore account for the lower mean platelet volume values recorded by the H6000 as compared with the HI machine. Differences in calibration might also have played a part, and this highlights the potential dangers of comparing serial counts made by different machinesfor example, where a patient is followed up in a specialist department but has interim blood counts at a local centre.
It was hoped that some of the additional blood indices available from automated counters might be helpful in distinguishing the different rheumatic disease states, but this did not prove to be the case. As expected, SLE was characterised by pancytopenia; RA by low 
